Fibroblast growth factor 23 is associated with carotid plaque presence and area: The Northern Manhattan study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 9, 2015, Pages 2048-2053

  Shah, Nirav H ^a   Dong, Chuanhui ^a   Elkind, Mitchell S V ^c,e   Sacco, Ralph L ^a   Mendez, Armando J ^a   Hudson, Barry I ^a,b   Silverberg, Shonni ^d   Wolf, Myles ^b   Rundek, Tatjana ^a   Wright, Clinton B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Columbia University ^*  (United States)

^d NONE   (United States)

^e Department of Medicine   (United States)

Author keywords

atherosclerosis; epidemiology; fibroblast growth factors; glomerular filtration rate; risk factors

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR;

AGED; ARTICLE; BLACK PERSON; CAROTID ATHEROSCLEROSIS; CAROTID PLAQUE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RISK FACTOR; ADULT; BLOOD; CAROTID ARTERY; CAROTID ARTERY DISEASES; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; ECHOGRAPHY; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNITED STATES; URBAN POPULATION;

ADULT; AGED; BIOMARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW YORK CITY; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; URBAN POPULATION;

EID: 84940386677     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305945     Document Type: Article

References (36)

1. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M, HOST Investigators FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 2011 22 1913 1922. doi: 10.1681/ASN.2010121224
2. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M, Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008 359 584 592. doi: 10.1056/NEJMoa0706130
3. van Venrooij NA, Pereira RC, Tintut Y, Fishbein MC, Tumber N, Demer LL, Salusky IB, Wesseling-Perry K, FGF23 protein expression in coronary arteries is associated with impaired kidney function. Nephrol Dial Transplant 2014 29 1525 1532. doi: 10.1093/ndt/gft523
4. Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG, Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol 2012 60 200 207. doi: 10.1016/j.jacc.2012.03.040
5. Gutiérrez OM, Wolf M, Taylor EN, Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol 2011 6 2871 2878. doi: 10.2215/CJN.02740311
6. Scialla JJ, Lau WL, Reilly MP, Chronic Renal Insufficiency Cohort Study Investigators Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 2013 83 1159 1168. doi: 10.1038/ki.2013.3
7. Taylor EN, Rimm EB, Stampfer MJ, Curhan GC, Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J 2011 161 956 962. doi: 10.1016/j.ahj.2011.02.012
8. Nakayama M, Kaizu Y, Nagata M, Ura Y, Ikeda H, Shimamoto S, Kuma K, Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study. BMC Nephrol 2013 14 22. doi: 10.1186/1471-2369-14-22
9. Balci M, Kirkpantur A, Gulbay M, Gurbuz OA, Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int 2010 14 425 432. doi: 10.1111/j.1542-4758.2010.00480.x
10. Voigt M, Fischer DC, Rimpau M, Schareck W, Haffner D, Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma. Histopathology 2010 56 775 788. doi: 10.1111/j.1365-2559.2010.03547.x
11. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL, Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008 70 1200 1207. doi: 10.1212/01.wnl.0000303969.63165.34
12. Spence JD, Carotid plaque measurement is superior to IMT Invited editorial comment on: carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-Analysis-Yoichi Inaba, M.D., Jennifer A. Chen M.D., Steven R. Bergmann M.D., Ph.D. Atherosclerosis 2012 220 34 35. doi: 10.1016/j.atherosclerosis.2011.07.006
13. Wright CB, Dong C, Stark M, Silverberg S, Rundek T, Elkind MS, Sacco RL, Mendez A, Wolf M, Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). Neurology 2014 82 1700 1706. doi: 10.1212/WNL.0000000000000410
14. Panwar B, Jenny NS, Howard VJ, Wadley VG, Muntner P, Kissela BM, Judd SE, Gutiérrez OM, Fibroblast growth factor 23 and risk of incident stroke in community-living adults. Stroke 2015 46 322 328. doi: 10.1161/STROKEAHA.114.007489
15. Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y, Yatomi Y, Fukumoto S, Fujita T, Shimosawa T, Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int 2014 85 1103 1111. doi: 10.1038/ki.2013.332
16. Tattersall MC, Gassett A, Korcarz CE, Gepner AD, Kaufman JD, Liu KJ, Astor BC, Sheppard L, Kronmal RA, Stein JH, Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic Study of Atherosclerosis. Stroke 2014 45 3257 3262. doi: 10.1161/STROKEAHA.114.005669
17. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, Paik MC, Shea S, Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan Stroke Study. Stroke 2001 32 1725 1731
18. Kuo F, Gardener H, Dong C, Cabral D, Della-Morte D, Blanton SH, Elkind MS, Sacco RL, Rundek T, Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke 2012 43 1755 1760. doi: 10.1161/STROKEAHA.112.651059
19. Garimella PS, Ix JH, Katz R, Chonchol MB, Kestenbaum BR, de Boer IH, Siscovick DS, Shastri S, Hiramoto JS, Shlipak MG, Sarnak MJ, Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study. Atherosclerosis 2014 233 91 96. doi: 10.1016/j.atherosclerosis.2013.12.015
20. Mirza MA, Larsson A, Lind L, Larsson TE, Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 2009 205 385 390. doi: 10.1016/j.atherosclerosis.2009.01.001
21. Schoppet M, Hofbauer LC, Brinskelle-Schmal N, Varennes A, Goudable J, Richard M, Hawa G, Chapurlat R, Szulc P, Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study. J Clin Endocrinol Metab 2012 97 E575 E583. doi: 10.1210/jc.2011-2836
22. Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA, European Uremic Toxin (EUTox) Work Group FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 2012 23 2017 2025. doi: 10.1007/s00198-011-1838-0
23. Kestenbaum B, Sachs MC, Hoofnagle AN, Siscovick DS, Ix JH, Robinson-Cohen C, Lima JA, Polak JF, Blondon M, Ruzinski J, Rock D, de Boer IH, Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis. Circ Heart Fail 2014 7 409 417. doi: 10.1161/CIRCHEARTFAILURE.113.000952
24. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T, Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004 113 561 568. doi: 10.1172/JCI19081
25. Mirza MA, Alsiö J, Hammarstedt A, Erben RG, Michaëlsson K, Tivesten A, Marsell R, Orwoll E, Karlsson MK, Ljunggren O, Mellström D, Lind L, Ohlsson C, Larsson TE, Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol 2011 31 219 227. doi: 10.1161/ATVBAHA.110.214619
26. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM, Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000 87 E10 E17
27. Six I, Okazaki H, Gross P, Cagnard J, Boudot C, Maizel J, Drueke TB, Massy ZA, Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium. PLoS One 2014 9 e93423. doi: 10.1371/journal.pone.0093423
28. Prabhakaran S, Singh R, Zhou X, Ramas R, Sacco RL, Rundek T, Presence of calcified carotid plaque predicts vascular events: the Northern Manhattan Study. Atherosclerosis 2007 195 e197 e201. doi: 10.1016/j.atherosclerosis.2007.03.044
29. Mathew JS, Sachs MC, Katz R, Patton KK, Heckbert SR, Hoofnagle AN, Alonso A, Chonchol M, Deo R, Ix JH, Siscovick DS, Kestenbaum B, de Boer IH, Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). Circulation 2014 130 298 307. doi: 10.1161/CIRCULATIONAHA.113.005499
30. Ross R, Atherosclerosis-An inflammatory disease. N Engl J Med 1999 340 115 126. doi: 10.1056/NEJM199901143400207
31. Alsulaimani S, Gardener H, Elkind MS, Cheung K, Sacco RL, Rundek T, Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study. Stroke 2013 44 457 461. doi: 10.1161/STROKEAHA.112.676155
32. Elkind MS, Cheng J, Boden-Albala B, Paik MC, Sacco RL, Northern Manhattan Stroke Study Elevated white blood cell count and carotid plaque thickness: the Northern Manhattan Stroke Study. Stroke 2001 32 842 849
33. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, Rabbani LE, Sacco RL, Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 2002 33 31 37
34. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M, Chronic Renal Insufficiency Cohort Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol 2012 7 1155 1162. doi: 10.2215/CJN.13281211
35. Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M, Mineral metabolites and CKD progression in African Americans. J Am Soc Nephrol 2013 24 125 135. doi: 10.1681/ASN.2012070713
36. Faul C, Amaral AP, Oskouei B, FGF23 induces left ventricular hypertrophy. J Clin Invest 2011 121 4393 4408. doi: 10.1172/JCI46122